ArticleCardiovascular research2026

Unravelling mitochondrial succinate transport during I/R and devising a novel transport inhibitor show promise for targeting I/R injury, but will efficacy remain under more human-like conditions present during I/R?

Qian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.